The efficacy and safety of extended use of endostatin plus platinum-based doublet chemotherapy in patients with advanced non-small cell lung cancer: An analysis of a 10-year retrospective study.

Jing Zhao,Jianhua Wang,Xueqi Zhao,Yi Cheng,Qingsong Xi,Qi Mei,Guangyuan Hu

The efficacy and safety of extended use of endostatin plus platinum-based doublet chemotherapy in patients with advanced non-small cell lung cancer: An analysis of a 10-year retrospective study.

2019

Jing Zhao
Jianhua Wang
Xueqi Zhao
Yi Cheng
Qingsong Xi
Qi Mei
Guangyuan Hu

e20523Background: Endostatin is a potent inhibitor of angiogenesis developed and approved in China. We aimed to evaluated the efficacy and safety of extended use of endostatin with platinum-based c...

Keywords:

Oncology
Cell
Pathology
Lung cancer
Endostatin
Chemotherapy
Retrospective cohort study
Internal medicine
Medicine
Angiogenesis
in patient
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations